Matches in SemOpenAlex for { <https://semopenalex.org/work/W2741442038> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2741442038 abstract "Introduction Individuals receiving the human papillomavirus (HPV) vaccine develop high levels of circulating neutralising antibodies. However, data about antibody responses in the cervix are limited. Methods This study was designed to describe the course of IgA/IgG responses in cervical secretions and in serum after intramuscular administration of the HPV16/18 AS04-adjuvant vaccine. An enzyme linked immunosorbent assay for detection of IgA and IgG anti–HPVVLP was developed for this purpose. Results Immunoglobulin G seroconversion after the second dose was observed in 100% of the participants and remained 1 month after the third dose. Regarding IgG reactivity in cervical secretions, conversion was observed in 85% of women after the final dose. Immunoglobulin A seroconversion was observed in 76.7% of women after the third dose. Lower levels of IgA were detected in the cervical mucus (28.3%) and decreased to 23.3% after the last dose. Comparing local and systemic IgG responses, positivity in both serum and cervical samples was observed in 85%, whereas in 15% only, the serum was IgG antibody positive. A weak agreement between local and systemic IgA responses was observed. Only 18.3% of participants were local and systemic IgA positive, 58.4% were positive only in serum, 5% were positive only in the cervix, and 18.3% were both local and systemic IgA antibody negative. Conclusion After the third vaccination, there is a strong agreement between cervical and systemic IgG antibody responses and a weak agreement between cervical and systemic IgA antibody responses. The induction of IgA antibodies seems to be secondary to that of IgG antibodies in response to HPV intramuscular vaccination." @default.
- W2741442038 created "2017-08-08" @default.
- W2741442038 creator A5003056902 @default.
- W2741442038 creator A5017423550 @default.
- W2741442038 creator A5027279516 @default.
- W2741442038 creator A5036679263 @default.
- W2741442038 creator A5044811865 @default.
- W2741442038 creator A5048343503 @default.
- W2741442038 creator A5055608441 @default.
- W2741442038 creator A5069496630 @default.
- W2741442038 creator A5091419084 @default.
- W2741442038 date "2017-07-01" @default.
- W2741442038 modified "2023-10-06" @default.
- W2741442038 title "P1.03 Characterisation of immunoglobulin a/g responses during 3 doses of the human papillomavirus-16/18 aso4-adjuvanted vaccine" @default.
- W2741442038 doi "https://doi.org/10.1136/sextrans-2017-053264.111" @default.
- W2741442038 hasPublicationYear "2017" @default.
- W2741442038 type Work @default.
- W2741442038 sameAs 2741442038 @default.
- W2741442038 citedByCount "0" @default.
- W2741442038 crossrefType "proceedings-article" @default.
- W2741442038 hasAuthorship W2741442038A5003056902 @default.
- W2741442038 hasAuthorship W2741442038A5017423550 @default.
- W2741442038 hasAuthorship W2741442038A5027279516 @default.
- W2741442038 hasAuthorship W2741442038A5036679263 @default.
- W2741442038 hasAuthorship W2741442038A5044811865 @default.
- W2741442038 hasAuthorship W2741442038A5048343503 @default.
- W2741442038 hasAuthorship W2741442038A5055608441 @default.
- W2741442038 hasAuthorship W2741442038A5069496630 @default.
- W2741442038 hasAuthorship W2741442038A5091419084 @default.
- W2741442038 hasBestOaLocation W27414420381 @default.
- W2741442038 hasConcept C121608353 @default.
- W2741442038 hasConcept C126322002 @default.
- W2741442038 hasConcept C159654299 @default.
- W2741442038 hasConcept C203014093 @default.
- W2741442038 hasConcept C22070199 @default.
- W2741442038 hasConcept C2777451964 @default.
- W2741442038 hasConcept C2777740455 @default.
- W2741442038 hasConcept C2777863537 @default.
- W2741442038 hasConcept C2779102806 @default.
- W2741442038 hasConcept C2780898057 @default.
- W2741442038 hasConcept C71924100 @default.
- W2741442038 hasConceptScore W2741442038C121608353 @default.
- W2741442038 hasConceptScore W2741442038C126322002 @default.
- W2741442038 hasConceptScore W2741442038C159654299 @default.
- W2741442038 hasConceptScore W2741442038C203014093 @default.
- W2741442038 hasConceptScore W2741442038C22070199 @default.
- W2741442038 hasConceptScore W2741442038C2777451964 @default.
- W2741442038 hasConceptScore W2741442038C2777740455 @default.
- W2741442038 hasConceptScore W2741442038C2777863537 @default.
- W2741442038 hasConceptScore W2741442038C2779102806 @default.
- W2741442038 hasConceptScore W2741442038C2780898057 @default.
- W2741442038 hasConceptScore W2741442038C71924100 @default.
- W2741442038 hasLocation W27414420381 @default.
- W2741442038 hasOpenAccess W2741442038 @default.
- W2741442038 hasPrimaryLocation W27414420381 @default.
- W2741442038 hasRelatedWork W145946029 @default.
- W2741442038 hasRelatedWork W184478611 @default.
- W2741442038 hasRelatedWork W1886054339 @default.
- W2741442038 hasRelatedWork W1893802376 @default.
- W2741442038 hasRelatedWork W2018524935 @default.
- W2741442038 hasRelatedWork W2030725321 @default.
- W2741442038 hasRelatedWork W2037427290 @default.
- W2741442038 hasRelatedWork W2065386317 @default.
- W2741442038 hasRelatedWork W2078559538 @default.
- W2741442038 hasRelatedWork W2091184236 @default.
- W2741442038 hasRelatedWork W2131237309 @default.
- W2741442038 hasRelatedWork W2285699435 @default.
- W2741442038 hasRelatedWork W2416384423 @default.
- W2741442038 hasRelatedWork W2417418371 @default.
- W2741442038 hasRelatedWork W2419357588 @default.
- W2741442038 hasRelatedWork W2470057756 @default.
- W2741442038 hasRelatedWork W29877242 @default.
- W2741442038 hasRelatedWork W3030926918 @default.
- W2741442038 hasRelatedWork W3202220946 @default.
- W2741442038 hasRelatedWork W35386124 @default.
- W2741442038 isParatext "false" @default.
- W2741442038 isRetracted "false" @default.
- W2741442038 magId "2741442038" @default.
- W2741442038 workType "article" @default.